ReviewPublished 1 December 2025The use of observed-to-expected analyses as a signal detection tool in COVID-19 vaccine safety surveillance: lessons learned from an industry perspectiveLaurence Serradell · Antonella Fretta · Jenny Nachbar · Jill Dreyfus · Diana Garofalo · Arianna Lucini · Susan Mather · Daina Esposito · Anne-Laure Chabanon · Vincent Bauchau · Sarah SellersFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2025.1650992
Original ResearchPublished 14 November 2025Reporting rates of abnormal uterine bleeding after COVID-19 vaccination in South KoreaJae Min Lee · Seung Geun Yeo · Sung Soo Kim · Dong Choon ParkFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2025.1658412
Drug Safety and RegulationPublished 15 August 2025A national pharmacovigilance centre perspective on pandemic preparedness - lessons learned from the COVID-19 pandemicFlorence van Hunsel · Agnes KantFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2025.1644680
Environmental HealthPublished 9 May 2025Influence of environmental variability on meningitis in West African countries: pre- and post-vaccinationDiarra Diouf · Marta Martín-Rey · Belén Rodríguez-Fonseca · Ibrahima Diouf · Cheikh Dione · Ademola Akinbobola · Amadou T. GayeFrontiers in Environmental Healthdoi 10.3389/fenvh.2025.1531076
MalariaPublished 24 February 2025Malaria “chemoprevention and vaccination strategies” for children living in endemic areas of Africa: a reviewWinnie Nambatya · Moses Ocan · Bjarne Robberstad · Jane Achan · Richard IdroFrontiers in Malariadoi 10.3389/fmala.2025.1336324
Musculoskeletal DisordersPublished 13 December 2023Screening practices, efficacy, safety and adherence to biologic therapies in a South African tertiary hospitalMohammed Awad Eltoum Ahmed · Christiaan Scott · Ayanda Gcelu · Jonel Steffen · Thuraya Isaacs · Bridget HodkinsonFrontiers in Musculoskeletal Disordersdoi 10.3389/fmscd.2023.1281548
